MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Wen, Zhili ^a,b   Huang, Wei ^b   Feng, Yuliang ^b   Cai, Wenfeng ^b   Wang, Yuhua ^b   Wang, Xiaohong ^b   Liang, Jialiang ^b   Wani, Mashhood ^b   Chen, Jing ^b   Zhu, Pin ^c   Chen, Ji Mei ^c   Millard, Ronald W ^b   Fan, Guo Chang ^b   Wang, Yigang ^b  

^a NANCHANG UNIVERSITY   (China)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 377; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS VECTOR; 3' UNTRANSLATED REGION; MIRN377 MICRORNA, HUMAN; MIRN377 MICRORNA, RAT; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RESPONSE; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSDUCTION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HUMAN; LENTIVIRINAE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CELL CULTURE; CELL HYPOXIA; ECHOCARDIOGRAPHY; GENE SILENCING; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANIMALS; BLOTTING, WESTERN; CELL HYPOXIA; CELLS, CULTURED; ECHOCARDIOGRAPHY; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICRORNAS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907584618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104666     Document Type: Article

References (33)

1. Zhao T, Zhao W, Chen Y, Ahokas RA, Sun Y (2010) Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. Microvasc Res 80: 188-194.
2. Stewart DJ, Kutryk MJ, Fitchett D, Freeman M, Camack N, et al. (2009) VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol Ther 17: 1109-1115.
3. Yla-Herttuala S, Rissanen TT, Vajanto I, Hartikainen J (2007) Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 49: 1015-1026.
4. Huang W, Zhang D, Millard RW, Wang T, Zhao T, et al. (2010) Gene manipulated peritoneal cell patch repairs infarcted myocardium. J Mol Cell Cardiol 48: 702-712.
5. Copland IB (2011) Mesenchymal stromal cells for cardiovascular disease. J Cardiovasc Dis Res 2: 3-13.
6. Zhang D, Fan GC, Zhou X, Zhao T, Pasha Z, et al. (2008) Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 44: 281-292.
7. Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, et al. (2003) Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107: 2134-2139.
8. Samper E, Diez-Juan A, Montero JA, Sepulveda P (2013) Cardiac cell therapy: boosting mesenchymal stem cells effects. Stem Cell Rev 9: 266-280.
9. Wang Y, Zhang D, Ashraf M, Zhao T, Huang W, et al. (2010) Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 298: H275-286.
10. Liang J, Huang W, Yu X, Ashraf A, Wary KK, et al. (2012) Suicide gene reveals the myocardial neovascularization role of mesenchymal stem cells overexpressing CXCR4 (MSC(CXCR4)). PLoS One 7: e46158.
11. Hu W, Coller J (2012) What comes first: translational repression or mRNA degradation? The deepening mystery of microRNA function. Cell Res 22: 1322-1324.
12. Jeker LT, Bluestone JA (2013) MicroRNA regulation of T-cell differentiation and function. Immunol Rev 253: 65-81.
13. Zhang Z, Qin YW, Brewer G, Jing Q (2012) MicroRNA degradation and turnover: regulating the regulators. Wiley Interdiscip Rev RNA 3: 593-600.
14. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, et al. (2007) A microRNA signature of hypoxia. Mol Cell Biol 27: 1859-1867.
15. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, et al. (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883.
16. Hassel D, Cheng P, White MP, Ivey KN, Kroll J, et al. (2012) MicroRNA-10 regulates the angiogenic behavior of zebrafish and human endothelial cells by promoting vascular endothelial growth factor signaling. Circ Res 111: 1421-1433.
17. Hua Z, Lv Q, Ye W, Wong CK, Cai G, et al. (2006) MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1: e116.
18. Dejean E, Renalier MH, Foisseau M, Agirre X, Joseph N, et al. (2011) HypoxiamicroRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia 25: 1882-1890.
19. Lai Y, Zhang X, Zhang Z, Shu Y, Luo X, et al. (2013) The microRNA-27a: ZBTB10-specificity protein pathway is involved in follicle stimulating hormoneinduced VEGF, Cox2 and survivin expression in ovarian epithelial cancer cells. Int J Oncol 42: 776-784.
20. Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, et al. (2012) Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 107: 700-706.
21. Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, et al. (2012) MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 40: 761-774.
22. Wang R, Zhao N, Li S, Fang JH, Chen MX, et al. (2013) MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. Hepatology 58: 642-653.
23. Yue X, Wang P, Xu J, Zhu Y, Sun G, et al. (2012) MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A. Oncol Rep 27: 1200-1206.
24. Liu F, Lou YL, Wu J, Ruan QF, Xie A, et al. (2012) Upregulation of microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/perfusion injury in vivo and in vitro. Kidney Blood Press Res 35: 182-191.
25. Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, et al. (2009) An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem 284: 35134-35143.
26. Alaiti MA, Ishikawa M, Masuda H, Simon DI, Jain MK, et al. (2012) Upregulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesis. J Cell Mol Med 16: 2413-2421.
27. Jin Y, Chen Z, Liu X, Zhou X (2013) Evaluating the microRNA targeting sites by luciferase reporter gene assay. Methods Mol Biol 936: 117-127.
28. Arnaoutova I, George J, Kleinman HK, Benton G (2009) The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12: 267-274.
29. Huang W, Wang T, Zhang D, Zhao T, Dai B, et al. (2012) Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9. Stem Cells Dev 21: 778-789.
30. Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H (2011) microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt-and p53-dependent pathways and exerts cytoprotective effects. Am J Physiol Heart Circ Physiol 301: H1519-1530.
31. Staszel T, Zapala B, Polus A, Sadakierska-Chudy A, Kiec-Wilk B, et al. (2011) Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn 121: 361-366.
32. Cochain C, Channon KM, Silvestre JS (2013) Angiogenesis in the infarcted myocardium. Antioxid Redox Signal 18: 1100-1113.
33. Tomita S, Mickle DA, Weisel RD, Jia ZQ, Tumiati LC, et al. (2002) Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123: 1132-1140.